Drug FDA Class II Ongoing Failed specifications
Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, Rx Only, 30-count bottle, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC., Parsippany, NJ 07054, NDC 67877-501-30.
Ascend Laboratories, LLC Published Jun 10, 2026
Risk level
Class IIMay cause a temporary or reversible health problem; slight chance of serious harm.
Severity score 60/100
What should you do?
- Check whether you have this product, using the lot codes, UPCs, and dates listed below.
- Do not eat, serve, or sell the affected product.
- Return it to the place of purchase for a refund, or throw it away in a sealed bag so people and animals can’t get to it.
- Contact Ascend Laboratories, LLC or your place of purchase with questions, and see the source record below for full details.
Reason for recall
Failed Dissolution Specifications: Olmesartan Medoxomil content below specifications
Hazards
Failed Dissolution - Olmesartan Medoxomil Below Specification · primary
Affected products (1)
Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, Rx Only, 30-count bottle, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC., Parsippany, NJ 07054, NDC 67877-501-30.
AMLODIPINE AND OLMESARTAN MEDOXOMIL · 15,696 x 30's bottles
NDC: 67877-499, 67877-500, 67877-501, 67877-502, 67877-499-30, 67877-499-90, 67877-500-30, 67877-500-90, 67877-501-30, 67877-501-90, 67877-502-30, 67877-502-90
Lot codes: 24123460
Code info: Lot: 24123460, Expires: October 31, 2027.
Affected areas
Nationwide
Timeline
- InitiatedMay 5, 2026
- PublishedJun 10, 2026
- Recall number
- D-0556-2026
- Agency
- U.S. Food and Drug Administration
- Country
- US
FDA records come from the openFDA drug enforcement-report dataset — the agency's full weekly enforcement list. Most entries are not issued as consumer press releases, so they won't appear on fda.gov/recalls or in a web search. The source record link above resolves this exact recall by its number.